Current Trials

These are some of the clinical trials that GLCC are currently working on. Together with our clients, we strive to deliver the most efficient and cost-effective services.

Surgical

  • STICH

    • Surgical
    • PHASE III & IV
    • 2,425 participants
    • 125 sites globally

    Surgical Treatment for Ischemic Heart Failure (STICH) Trial is a multicentre, international, randomised trial comparing medical treatment + CABG, and medical treatment + CABG + surgical ventricular restoration (SVR) in 2,425 patients. Follow -up will be between 2 to 6 years.

    More about the STICH study

Trial Types

Our People

At GLCC we strongly believe people are our biggest asset. Together with support from national and international academia, research registrars and fellows, we are dedicated to achieving the highest possible standard in clinical research.

Benefits of conducting trials in New Zealand

  • Well established clinical trial infrastructure
  • Excellent recruitment and retention rates
  • High standard of medical practice
  • High standard of clinical trial data
  • Adherence to ICH/GCP and FDA regulations
  • Regulatory framework based on European and American systems

Learn more about conducting clinical trials in New Zealand